(FIE) Fielmann Aktiengesellschaft - Ratings and Ratios

Fielmann Group AG is a leading player in the vision care and audiology industry, operating in multiple countries including Germany, Switzerland, Austria, and internationally. The company has a diverse product portfolio that includes visual aids such as glasses, frames, lenses, sunglasses, contact lenses, and accessories, as well as hearing aid systems and personal protective equipment. Fielmanns products are sold under various brand names, including Fielmann, Optika Clarus, and SVS VISION, among others.

The companys business model is diversified across multiple sales channels, including digital sales, retail stores, and e-commerce platforms such as Befitting. With a history dating back to 1972, Fielmann has established itself as a prominent player in the industry, and its recent name change from Fielmann Aktiengesellschaft to Fielmann Group AG in July 2023 reflects its evolving business strategy.

From a technical analysis perspective, Fielmanns stock price is currently trading near its 52-week high, with a last price of 55.10 EUR. The stocks short-term moving averages (SMA20 and SMA50) are converging, indicating a potential trend reversal. With an ATR of 1.36, representing 2.46% of the last price, the stocks volatility is relatively moderate.

Fundamentally, Fielmanns market capitalization stands at approximately 4.7 billion EUR, with a P/E ratio of 28.87 and a forward P/E of 20.16. The companys return on equity (RoE) is 11.95%, indicating a relatively stable and profitable business. Given the companys strong brand presence, diversified product portfolio, and expanding sales channels, we forecast that Fielmanns stock price will continue to appreciate in the near term, potentially reaching 60 EUR within the next 6-12 months, driven by its improving earnings and expanding market share.

Our forecast is based on the convergence of the stocks short-term moving averages, the companys improving fundamental metrics, and the overall growth trend in the vision care and audiology industry. With a target price of 60 EUR, we expect Fielmanns stock to outperform the broader market in the coming months, driven by its strong brand presence and expanding business operations.